305
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Investigation of the prevalence of genes conferring resistance to carbapenems in Pseudomonas aeruginosa isolates from burn patients

, , , &
Pages 1153-1159 | Published online: 07 May 2019

References

  • World Health Organization. Burns. WHO; 2014 Available from: http://www.who.int/news-room/fact-sheets/detail/burns. Accessed March 6, 2018.
  • Sadikot RT, Blackwell TS, Christman JW, Prince AS. Pathogen–host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med. 2005;171(11):1209–1223. doi:10.1164/rccm.200408-1044SO15695491
  • Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev. 2009;22(4):582–610. doi:10.1128/CMR.00040-0919822890
  • Patel G, Bonomo R. “Stormy waters ahead”: global emergence of carbapenemases. Front Microbiol. 2013;4(48):1–17. doi:10.3389/fmicb.2013.0000123346082
  • Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug resistant, extensively drug resistant and pandrug resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x21793988
  • Codjoe FS, Donkor ES. Carbapenem resistance: a review. Med Sci. 2017;6(1):1–28.
  • Cobos-Trigueros N, Solé M, Castro P, et al. Acquisition of Pseudomonas aeruginosa and its resistance phenotypes in critically ill medical patients: role of colonization pressure and antibiotic exposure. Crit Care. 2015;19(1):218. doi:10.1186/s13054-015-0916-725936721
  • Mahon CR, Lehman DC, Manuselis G Jr. Textbook of Diagnostic Microbiology. Amsterdam: Elsevier Health Sciences; 2014.
  • Patel JB, Cockerill IIIFR, Eliopoulos GM, et al. Performance Standards for Antimicrobial Susceptibility Testing (M100S); 26th Ed. Clinical and Laboratory Standards Institute (CLSI). USA: Wayne; 2016.
  • Maroui I, Barguigua A, Aboulkacem A, et al. First report of VIM-2 metallo-β-lactamases producing Pseudomonas aeruginosa isolates in Morocco. J Infect Chemother. 2016;22(3):127–132. doi:10.1016/j.jiac.2015.11.00826711231
  • Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.00221398074
  • Wolter DJ, Acquazzino D, Goering RV, Sammut P, Khalaf N, Hanson ND. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Clin Infect Dis. 2008;46(12):137–141. doi:10.1086/52408018171229
  • Khosravi AD, Mihani F. Detection of metallo-β-lactamase–producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Diagn Microbiol Infect Dis. 2008;60(1):125–128. doi:10.1016/j.diagmicrobio.2007.08.00317900848
  • van Kleef E, Luangasanatip N, Bonten MJ, Cooper BS. Why susceptible bacteria are resistant to hospital infection control. Wellcome Open Res. 2017;2:1–32. doi:10.12688/wellcomeopenres.10308.128239665
  • Lari AR, Azimi L, Soroush S, Taherikalani M. Low prevalence of metallo-beta-lactamase in Pseudomonas aeruginosa isolated from a tertiary burn care center in Tehran. Int J Immunopathol Pharmacol. 2015;28(3):384–389. doi:10.1177/039463201557834325816399
  • Shokri D, Khorasgani MR, Zaghian S, et al. Determination of acquired resistance profiles of Pseudomonas aeruginosa isolates and characterization of an effective bacteriocin-like inhibitory substance (BLIS) against these isolates. Jundishapur J Microbiol. 2016;9(8):1–8. doi:10.5812/jjm
  • Palavutitotai N, Jitmuang A, Tongsai S, Kiratisin P, Angkasekwinai N. Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections. PLoS One. 2018;13(2):1–13. doi:10.1371/journal.pone.0193431
  • Moosavian M, Rahimzadeh M. Molecular detection of metallo-β-lactamase genes, blaIMP-1, blaVIM-2 and blaSPM-1 in imipenem resistant Pseudomonas aeruginosa isolated from clinical specimens in teaching hospitals of Ahvaz, Iran. Iranian J Microbiol. 2015;7(1):2.
  • Tarashi S, Goudarzi H, Erfanimanesh S, Pormohammad A, Hashemi A. Phenotypic and molecular detection of metallo-beta-lactamase genes among imipenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients with burn injuries. Arch Clin Infect Dis. 2016;11(4):1–6. doi:10.5812/archcid
  • Bushnell G, Mitrani-Gold F, Mundy LM. Emergence of New Delhi metallo-β-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance. Int J Infect Dis. 2013;17(5):e325–333. doi: 10.5812/jjm.27249 Published online 2016 Mar 3.23332300
  • Falahat S, Mana Shojapour M, Sadeghi A. Detection of KPC carbapenemase in Pseudomonas aeruginosa isolated from clinical samples using modified hodge test and boronic acid phenotypic methods and their comparison with the polymerase chain reaction. Jundishapur J Microbiol. 2016;9(9):e27249. doi:10.5812/jjm27800140
  • Evans BA, Amyes SGB. OXA –lactamases. Clin Microbiol Rev. 2014;27:241–263. doi:10.1128/CMR.00117-1324696435
  • Mohamed SE, Alobied A, Mohamed Hussien W, Saeed MI. blaOXA-48 carbapenem resistant Pseudomonas aeruginosa clinical isolates in Sudan. J Adv Microbiol. 2018;10(4):1–5. doi:10.9734/JAMB/2018/34964
  • Juan CN, Oliver A. Carbapenemases in Pseudomonas spp. Enferm Infecc Microbiol Clin. 2010;28:19–28. doi:10.1016/S0213-005X(10)70004-520172419
  • Savard P, Perl TM. Combating the spread of carbapenemases in Enterobacteriaceae: a battle that infection prevention should not lose. Clin Microbiol Infect. 2014;20(9):854–861. doi:10.1111/1469-0691.1274824980472
  • Taee S. Investigation of prevalence of genes encoding resistance to carbapenems in Pseudomonas areuginosa isolates from burn patients in Taleghani burn hospital, Ahvaz, Iran [Msc thesis]. Yasouj: Faculty of Basic Sciences, Islamic Azad University; 2016.